IndraLab

Statements

Amodiaquine inhibits transcription, DNA-templated. 3 / 3
| 2 1
sparser
"Herein, we report a novel activity of the FDA-approved antimalarial drug amodiaquine which inhibits rRNA transcription, a rate-limiting step for ribosome biogenesis, in a dose-dependent manner."
31285544
reach
"Herein, we report a novel activity of the FDA approved antimalarial drug amodiaquine which inhibits rRNA transcription, a rate limiting step for ribosome biogenesis, in a dose dependent manner."
31285544
reach
"Herein, we report a novel activity of the FDA approved antimalarial drug amodiaquine which inhibits rRNA transcription, a rate limiting step for ribosome biogenesis, in a dose dependent manner."
31285544